Praxis Reinfeld Mitte

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for atherosclerotic cardiovascular disease. The center's work aims to reduce the risk of major adverse cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction, and non-elective coronary revascularization.

• Atherosclerotic Heart and Blood Vessel Disease
• Major Adverse Cardiovascular Events (MACE)
• Innovative Lipid-Modifying Therapies

Through its research, the center contributes significantly to the development of new therapeutic strategies that enhance the efficacy of existing lipid-modifying treatments, offering hope to patients with insufficiently managed cardiovascular conditions.

Specializing in the intersection of diabetes and cardiovascular health, the center conducts pivotal studies to evaluate the efficacy of novel treatments for Type 2 Diabetes Mellitus. The research focuses on reducing the incidence of major cardiovascular events in patients with high cardiovascular risk.

• Type 2 Diabetes Mellitus
• Cardiovascular Risk Management
• Comparative Efficacy of Diabetes Treatments

The center's research efforts are instrumental in advancing the understanding of how diabetes medications can be optimized to improve cardiovascular outcomes, thereby enhancing the quality of life for patients with Type 2 Diabetes.

Renowned for its expertise in infectious disease research, the center is pioneering studies on vaccines for the prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease. This research is particularly focused on older adults with a history of urinary tract infections.

• Invasive E. coli Disease Prevention
• Vaccine Efficacy Studies
• Microbiological Confirmation Techniques

By advancing vaccine development, the center plays a crucial role in protecting vulnerable populations from serious bacterial infections, thereby contributing to public health and safety.